NDVAX | VSCAX | NDVAX / VSCAX | |
Total Expense Ratio | 1.21 | 1.10 | 110% |
Annual Report Gross Expense Ratio | 1.22 | 1.10 | 111% |
Fund Existence | 14 years | 26 years | - |
Gain YTD | -3.358 | 8.932 | -38% |
Front Load | 6% | 6% | 105% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.7B | 7.51B | 36% |
Annual Yield % from dividends | 1.28 | 0.32 | 404% |
Returns for 1 year | -9.67 | 2.33 | -415% |
Returns for 3 years | 7.69 | 49.64 | 15% |
Returns for 5 years | 31.22 | 106.26 | 29% |
Returns for 10 years | 43.13 | 39.02 | 111% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GINNX | 66.87 | 0.18 | +0.27% |
Guinness Atkinson™ Global Inntrs Instl | |||
BPSIX | 27.04 | 0.07 | +0.26% |
Boston Partners Small Cap Value II I | |||
GABSX | 45.35 | 0.03 | +0.07% |
Gabelli Small Cap Growth AAA | |||
AZEMX | 13.27 | -0.01 | -0.08% |
Alger Emerging Markets Z | |||
MIDJX | 33.05 | -0.06 | -0.18% |
MFS International New Discovery R4 |